Venus Remedies Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 13.37 Cr
as on 05-07-2024
- Company Age 35 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 909.48 Cr
as on 05-07-2024
- Revenue -6.13%
(FY 2023)
- Profit -40.87%
(FY 2023)
- Ebitda 124.63%
(FY 2023)
- Net Worth 6.37%
(FY 2023)
- Total Assets 5.22%
(FY 2023)
About Venus Remedies
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 526953 and on the National Stock Exchange(NSE) under VENUSREM.
The Corporate was formerly known as Venus Glucose Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 13.37 Cr.
The company has closed loans amounting to ₹909.48 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Venus Remedies Limited India are Pawan Chaudhary as CFO and Neha as Company Secretary. Pawan Chaudhary, Manu Chaudhary, Peeyush Jain, and Seven other members serve as directors at the Company.
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Venus Remedies Limited offer?
Venus Remedies Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Antibiotic Injection, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Antibacterial Drugs, Infusion Syringes & Supplies, Syringes, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Venus Remedies?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Chaudhary  | Managing Director | 15-Sep-1989 | Current |
| Neha | Company Secretary | 11-Apr-2011 | Current |
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manu Chaudhary | Whole-Time Director | 10-Oct-2005 | Current |
| Peeyush Jain | Whole-Time Director | 28-Sep-1994 | Current |
| Suresh Chadha | Director | 26-Dec-2005 | Current |
| Ashutosh Jain | Whole-Time Director | 01-May-2007 | Current |
Dr Wenzel  | Director | 26-Dec-2005 | Current |
| Navdeep Sud | Director | 20-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Venus Remedies.
Venus Remedies Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.13% decrease. The company also saw a substantial fall in profitability, with a 40.87% decrease in profit. The company's net worth moved up by a moderate rise of 6.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Remedies?
In 2023, Venus Remedies had a promoter holding of 41.76% and a public holding of 58.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spine Software Systems Private LimitedActive 11 years 11 monthsPawan Chaudhary, Peeyush Jain and 1 more are mutual person
Sunev Pharma Solutions LimitedActive 17 years 11 monthsPawan Chaudhary, Manu Chaudhary and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Trusteeship Services Limited Creation Date: 10 Feb 2015 | ₹16.57 Cr | Satisfied |
Dena Bank Creation Date: 31 Mar 2014 | ₹2.00 Cr | Satisfied |
Andhra Bank Creation Date: 09 Jan 2014 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Venus Remedies?
Venus Remedies has a workforce of 1119 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
